GC
ACOR

Globeflex Capital’s Acorda Therapeutics ACOR Stock Holding History

Globeflex Capital’s Portfolio ACOR Stock Details ACOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-243
Closed -$973K – 584
2015
Q2 		$973K Buy
+243
New +$939K 0.18% 224
2014
Q3 		– Sell
-310
Closed -$1.25M – 676
2014
Q2 		$1.25M Hold
310
– – 0.14% 192
2014
Q1 		$1.41M Sell
310
-5
-2% -$20.2K 0.16% 156
2013
Q4 		$1.1M Buy
+315
New +$1.23M 0.13% 197

Other funds holding ACOR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Globeflex Capital's ACOR Position: Q3 2015 in Review

Globeflex Capital sold out of Acorda Therapeutics (ACOR) in Q3 2015, closing a stake of 243 shares — an estimated $973K sold.

Globeflex Capital first reported a position in ACOR in Q4 2013 and held it in 4 quarters. The position peaked at $1.41M in Q1 2014. 176 funds tracked by Wall St. Rank hold ACOR as of Q3 2015.

  • Globeflex Capital reported no remaining Acorda Therapeutics position as of Q3 2015 after selling out during the quarter.
  • Globeflex Capital sold 243 Acorda Therapeutics shares in Q3 2015, an estimated $973K.
  • Globeflex Capital first reported a position in Acorda Therapeutics in Q4 2013 and held it in 4 quarters.
  • Globeflex Capital's Acorda Therapeutics position peaked at $1.41M in Q1 2014.
  • 176 funds tracked by Wall St. Rank held Acorda Therapeutics as of Q3 2015.

Based on Globeflex Capital's 13F filing for Q3 2015, filed 9 Nov 2015.